Novel Mouse Model Of Demyelinating Disorder

Main Category: Multiple Sclerosis
Also Included In: Biology / Biochemistry;  Genetics
Article Date: 15 Jan 2010 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:4 and a half stars

4.2 (10 votes)

Healthcare Prof:4 stars

4 (2 votes)


In the February 1st issue of G&D, Dr. Brian Popko (The University of Chicago) and colleagues describe how mutation of a gene called ZFP191 leads to disordered CNS myelination in mice -- reminiscent of what is seen in human multiple sclerosis (MS) patients.

The paper will be released online ahead of print at http://www.genesdev.org.

MS is a chronic autoimmune disorder, in which the body attacks and destroys the myelin sheath that insulates and protects nerve fibers of the central nervous system (the brain, spinal cord and optic nerves). Demyelination disrupts the conduction of electrical impulses along nerve fibers, and results in regional neural deficits. MS symptoms range from tingling and numbness in limbs, to loss of vision and paralysis.

It is estimated that MS affects 400,000 people in the US and approximately 2.5 million worldwide.

Dr. Popko and colleagues identified a gene called ZFP191 as being necessary for the development of oligodendrocyte cells, which - in their fully mature form - produce myelin. The researchers found that mice harboring a single mutation in ZFP191 display tremors and seizures, caused by a severe deficiency in CNS myelination.

ZFP191 appears to be the first factor identified to be critical for the myelinating function of oligodendrocytes.

The failure of Zfp191-mutant mouse oligodendrocytes to successfully myelinate their targets is reminiscent of human MS lesions, where re-myelination of damaged tracts fails to occur efficiently even when apparently mature oligodendrocytes are present in the area.

While further research to delineate the precise targets of ZFP191 is needed, this work holds promising clinical value as a potential therapeutic pathway to promote re-myelination, reduce the accumulation of MS lesions and slow disease progression.

Source: Heather Cosel-Pieper
Cold Spring Harbor Laboratory

Article adapted by Medical News Today from original press release.
Visit our multiple sclerosis section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Heather Cosel-Pieper. "Novel Mouse Model Of Demyelinating Disorder." Medical News Today. MediLexicon, Intl., 15 Jan. 2010. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/176162.php>

APA
Heather Cosel-Pieper. (2010, January 15). "Novel Mouse Model Of Demyelinating Disorder." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/176162.php.

Please note: If no author information is provided, the source is cited instead.




Multiple Sclerosis

Most Popular Articles



Follow Our Multiple Sclerosis News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Multiple Sclerosis Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »